▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory

Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansio...

Business Wire

MISSISSAUGA, Canada: Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold. Located in Mississauga, Canada, the expanded facility marks the addition of specialized equipment and analytical techniques, tailored to offer comprehensive analytical support for drug product programs. The laboratory has expanded to encompass water activity measurements, intrinsic dissolution studies, additional glove box systems, an added suite of HPLCs, new stability chambers and gas chromatography.

Eurofins CDMO Alphora Inc is committed to supporting the development and manufacturing of life-saving therapies and providing the highest standards of quality, customized support, and expert analysis to its clients. Through the Drug Product Analytical Services Laboratory expansion and Eurofins CDMO Alphora Inc’s drug product capabilities and extensive suite of Solid-State Research and Development, Eurofins CDMO Alphora is well positioned to support even the most challenging drug development programs.

To learn more, please visit:
https://www.eurofins.com/biopharma-services/cdmo/services/small-molecules-dp-development-manufacturing/

About Eurofins CDMO Alphora Inc.
Eurofins CDMO is a leading global Contract Development and Manufacturing Organization that provides clients with active pharmaceutical ingredients (“API’s”) / drug substance and drug product development for small molecules, biologics and phytocannabinoids via synthetic route. Its service offering encompasses drug substance/API development, solid state research and development, pre-formulation, formulation and development, analytical development, Non-GMP & GMP manufacturing, upstream development, downstream development, ADC Conjugation. Operating with facilities in Europe, North America and India, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada.

About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With ca. 62,000 staff across a network of more than 900 laboratories in over 1,000 companies in 62 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Axyon AI: Italian Artificial Intelligence for Finance applications

Axyon AI offers an AI platform specifically designed for asset management, with several interesting strengths for those approaching machine/deep learning…

Italian Artificial Intelligence tackles medical emergencies at sea

Mermaid-AI is a telehealth platform at sea based on a visor equipped with an AR, medical Artificial Intelligence algorithms, satellite communications…

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

ITALIAN PROJECT AWARDS 2023: the best IT projects of the year, awarded

Now in its third edition, the initiative is targeted at the ICT professional world and honours projects based on innovative ideas and technologies, realised…

Most read

AHSG Announces Leadership Transition as CEO Mark Smith Joins Board of…

AHSG, a technology-driven, healthcare workforce solutions company, today announced Mark Smith will be stepping down at the end of June as Chief Executive…

Verituity Raises $18.8M to Accelerate its B2B and B2C Verified Payout…

Verituity, a leading provider of intelligent, verified payouts solutions, announced the successful close of an $18.8 million funding round led by Sandbox…

HubStar Launches H2O, a Revolutionary New Approach to Optimizing Occupancy…

HubStar, a leader in dynamic workplace management technology, today announced the launch of H2O, the first ever hybrid occupancy platform designed to…

SMILE Health 2024: CareQuest Innovation Partners and MATTER Announce Largest…

CareQuest Innovation Partners, a company focused on validating and scaling transformative solutions to improve overall health through oral health for…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!